OPKO Health $230 million convertible senior notes offering
The 3.75% convertible notes are due 2029
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Auna $550 million secured term loan refinancing
We advised Auna on the transaction
Solid Biosciences $109 million private placement
The PIPE includes common stock and pre-funded warrants
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
Auna exchange offer and consent solicitations
We advised the Auna on the transaction
Merit Medical Systems $747.5 million convertible senior notes offering
The 3% convertible senior notes are due 2029
Evolent Health $402.5 million convertible notes offering
The convertible notes are due 2029
Innovent Biologics HK$2.4 billion placement of shares
The shares are listed on the Hong Kong Stock Exchange
Atara Biotherapeutics $100 million at-the-market offering
The stock is listed on Nasdaq